Drug intelligence / Profile preview

Herbavac CSF Green

Development stage
Unknown
Lead developer
BioApp
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

HERBAVAC CSF Green Marker is a plant-derived recombinant protein subunit vaccine designed for the prevention of Classical Swine Fever (CSF) in pigs. Developed by Coree Beijing in collaboration with BioApp, the vaccine utilizes the E2 envelope protein of the Classical Swine Fever Virus (CSFV) expressed in plant systems, such as *Nicotiana benthamiana*. This "green" technology offers a safer production method compared to traditional live-attenuated vaccines, as it eliminates the risk of viral reversion or environmental contamination. A key feature of HERBAVAC CSF Green Marker is its status as a marker vaccine, which enables the Differentiating Infected from Vaccinated Animals (DIVA) strategy. This allows for effective disease surveillance and eradication programs by distinguishing between animals that have been vaccinated and those that have been naturally infected. It is the first plant-produced veterinary vaccine to be approved for commercial use.

Brand names
Herbavac CSF GreenHERBAVAC CSF Green Marker
Other names
Classical Swine Fever Virus E2 plant-derived vaccineCSFV E2 subunit vaccineHerbavac CSF Green Marker
02

Targets

Classical swine fever virus E2-specific B-cell receptors and T-cell receptors

Beyond the preview

Go deeper on Herbavac CSF Green.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herbavac CSF Green.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call